Hfq binds broadly to cellular mRNAs and sRNAs [13][14][15] , in line with its main biological 51 functions. Hfq can bind RNAs through multiple interfaces of its homohexameric structure. The 52 surface containing the N-terminal α-helices is referred as the "proximal face" of the Hfq hexamer, 53
Abstract 23
RNA binding proteins play myriad roles in controlling and regulating RNAs and RNA-mediated 24 functions, often through simultaneous binding to other cellular factors. In bacteria, the RNA 25 chaperone Hfq modulates post-transcriptional gene regulation. Absence of Hfq leads to the loss 26 of fitness and compromises the virulence of bacterial pathogens. Using live-cell super-resolution 27 imaging, we are able to distinguish Hfq binding to different sizes of cellular RNAs. We demonstrate 28 that under normal growth conditions, Hfq exhibits widespread mRNA binding activity. Particularly, 29 the distal face of Hfq contributes mostly to the mRNA binding in vivo. In addition, binding of Hfq 30 to these mRNAs can recruit RNase E to promote turnover of these mRNAs in an sRNA-31 independent manner, providing one mechanism to release Hfq from the pre-bound mRNAs. 32
Finally, our data indicate that sRNAs, once expressed, can either co-occupy Hfq with the mRNA 33 or displace the mRNA from Hfq, suggesting mechanisms through which sRNAs rapidly access 34
Hfq to induce sRNA-mediated gene regulation. Our data collectively demonstrate that Hfq 35 dynamically changes its interactions with different RNAs in response to changes in cellular 36 conditions. 37 38
Main Text 39
In all three kingdoms of life, RNA binding proteins (RBPs) play myriad roles in controlling and 40 regulating RNAs and RNA-mediated functions. As one of the most abundant RNA binding proteins 41 in bacterial cells, Hfq is an important and prevalent post-transcriptional gene regulator [1] [2] [3] . The 42 most recognized functions of Hfq as a chaperone of small regulatory RNA (sRNA)-mediated gene 43 regulation are to stabilize sRNAs and to promote sRNAs binding to their cognate target mRNAs 3 . Binding of sRNAs to target mRNAs further leads to changes in the translation activity and the 45 stability of the mRNAs 4,5 . Moreover, other functions of Hfq in regulating translation and 46 degradation of mRNAs independent of sRNA-mediated regulatory pathway have also been 47 reported 6-10 . The functional importance of Hfq is evident by the fact that loss of Hfq compromises 48 complexes are stable with a lifetime of >100 minutes [34] [35] [36] . However, under stress conditions, 75 induced sRNAs can regulate target mRNAs within minutes, raising a long-standing question of 76 how sRNAs can rapidly access Hfq that might be tightly bound by pre-existing cellular RNAs. To 77 address this question, a model of RNA exchange on Hfq, i.e. a RNA can actively displace another 78 RNA from Hfq, was proposed to account for the fast sRNA-mediated stress response 2,3,37 . While 79 in vitro biophysical experiments can be used to measure the affinity of RBP binding to many 80 different RNAs under many different controllable conditions, the in vitro nature of these 81 experiments makes it difficult to replicate the concentrations, compartmentalization, crowding, 82 competitive binding and changes in cellular conditions that can affect the behavior and function 83 of RBPs in live cells. Therefore, the mechanism(s) that can recycle Hfq from pre-bound RNAs in 84 live cells remains to be elucidated. 85
In order to address this question in a cellular context, we sought to measure the diffusivity 86 of Hfq in live Escherichia. coli cells, using single-molecule localization microscopy (SMLM) 38 , with 87 a rationale that the diffusivity is affected by the molecular weight of the molecules, and therefore 88 can report the interactions between Hfq with different cellular components. By measuring Hfq 89 diffusivity under a variety of cellular conditions in combination with other biochemical assays, we 90 demonstrate that Hfq dynamically changes its interactions with different RNAs in response to 91 changes in cellular conditions, reveal a new sRNA-independent pathway for Hfq-regulated mRNA 92 turnover, and illustrate that the two classes of sRNA can gain access to mRNA pre-bound Hfq 93 through different mechanisms. 94
95
Results 96
Cellular Hfq freely diffuses in the absence of stress 97
Hfq was tagged by a photo-switchable fluorescent protein (FP), mMaple3 39 , at the C-terminus and 98 the fused hfq gene was integrated into the genomic locus to replace the wild-type (WT) hfq 99 (denoted as "hfq-mMaple3", Methods). The strain harboring hfq-mMaple3 showed comparable 100 growth curve as the WT strain, whereas Δhfq showed a growth defect ( Figure S1 ). In addition, 101
Hfq-mMaple3 showed activity comparable to WT Hfq protein, as revealed by Northern blots of 102 RyhB-mediated sodB mRNA degradation, and MicA-mediated ompA mRNA degradation ( Figure  103 S2). 104
We performed single-particle tracking using SMLM in two dimensions (2D). Imaging 105 conditions and parameters for applying tracking algorithm were optimized using fixed samples as 106 the control ( Figure S3 ). We first tracked Hfq-mMaple3 in live cells grown at exponential phase 107 (referred as "no treatment", or "NT" case). In the NT condition, Hfq-mMaple3 exhibited a relatively 108 uniform distribution within the cell (Figure 1b 
Binding of mRNAs to Hfq decreases its diffusivity primarily through the distal face of Hfq 120
We first tested the effect of mRNA on Hfq-mMaple3 diffusivity by treating the cells with rifampicin 121 (Figure 2a ), an antibiotic that inhibits transcription and results in the loss of most cellular mRNAs. 122
We estimated the effective diffusion coefficient (D) by fitting the power function to the mean 123 squared displacement (MSD) as a function of time lag (Δt) (Figure 2b ). Transcription inhibition 124 increased the diffusivity of Hfq-mMaple3 ( Figure 2b ), suggesting that a fraction of Hfq-mMaple3 125 proteins are associated with cellular mRNAs, consistent with previous reports 40 . As a control, 126 mMaple3 protein alone did not show any changes in diffusivity upon rifampicin treatment (Figure  127   S4).  128   We next introduced point mutations at each RNA binding face of Hfq-mMaple3 25,44 , and  129 imaged these mutant Hfq-mMaple3 proteins under NT and rifampicin treated conditions. With 130 rifampicin treatment, all Hfq mutants exhibited similar diffusivity. However, mutations on different 131 interfaces changed Hfq diffusivity in the NT case to different levels, suggesting that mutation on 132 different faces changed the ability of Hfq to bind cellular mRNAs. Specially, both proximal face 133 mutants (Q8A and F42A) exhibited similar diffusivity as the WT Hfq-mMaple3; both rim mutations 134 (R16A and R19D) had a minor increase in diffusivity under NT condition; and both distal face 135 mutations (Y25D and K31A) led to a large increase in the diffusivity under NT condition ( Figure  136 2c). Comparison of the WT and the mutant Hfq-mMaple3 proteins supports conclusions that Hfq 137 binds mRNAs in the cell and that binding of mRNAs is primarily achieved through the interactions 138 with the distal face of Hfq, whereas the rim also contributes to the mRNA binding in a minor way. 139 140
Most Hfq proteins are occupied by mRNAs in the cell during exponential growth 141
Under our experimental conditions, mMaple3 protein alone had a D of 1.8±0.2 µm 2 /s (fit with a 142 power function) or 2.7±0.2 µm 2 /s (fit with a linear function) ( Figure S4 ), close to the reported range 143 of D for fluorescent proteins (~27 kDa) (3-8 µm 2 /s) 45 . WT and mutant Hfq-mMaple3 proteins upon 144 rifampicin treatment consistently showed a diffusion coefficient of 1.2-1.5 µm 2 /s ( Figure 2c ). 145
Considering the power-law dependence of D on Mw of biomolecules 45 , such a change in D 146 corresponds to a 2-4 fold change in Mw (~50-100 kDa), which is smaller than hexameric Hfq-147 mMaple3 (~220 kDa). This observation suggests that in the absence of RNA binding, a fraction 148 of Hfq may exist as monomer in the cell. WT Hfq-mMaple3 in the NT case had a D of 0.50±0.07 149 µm 2 /s, corresponding to a Mw of 2.1 MDa, again assuming the power-law relationship between D 150 and Mw. Considering the average length of bacterial mRNAs to be 1 kb (~330 kDa), and Mw of 151 bacterial ribosome (~2.5 MDa), this reduction in D supports the interpretation that a significant 152 fraction of WT Hfq proteins are associated with mRNAs in the NT case, and that a fraction of the 153 associated mRNAs are translated by the ribosomes. In addition, previous experiments have 154 measured the diffusion coefficient of ribosomes or ribosomal complexes to be 0.04-0.5 µm 2 /s 46-155 48 . The average D of WT Hfq-mMaple3 under NT condition is at the upper limit of range for 156 ribosomes, again indicating the D value of mRNA-associated Hfq very likely represents an 157 average value of both untranslated and translated mRNAs. 158
In order to estimate the fraction of mRNA-associated Hfq-mMaple3, we plotted log(osd) in 159 a histogram. Consistent with D values, distribution of osd overall shifted to larger values with 160 rifampicin treatment compared to the NT case ( Figure S5 ). We fit the distribution of log(osd) of 161 the rifampicin treated case with single Gaussian peak and used the fit parameters (the center and 162 the width) to constrain the fitting for other Hfq-mMaple3 constructs under different conditions. For 163 the WT Hfq-mMaple3, in the NT case, about 95±4% of the population was mRNA-associated, 164 consistent with previous hypothesis that Hfq proteins are largely occupied in the cell 2,3,37 . Y25D 165 and K31A mutants had the most compromised mRNA binding ability, with 33±6% and 32±4% of 166 the population was mRNA-associated, respectively ( Figure 2d ). 167 168
Hfq is deficient in releasing mRNAs without interactions with RNase E 169
Hfq has been demonstrated to interact with the C-terminal scaffold region of RNase E 26-28 . To 170 study whether the interaction with RNase E affects the diffusivity of Hfq, we imaged Hfq-mMaple3 171 in two RNase E mutant strains. The rne131 mutant strain has RNase E truncated by the last 477 172 amino acid residues 49 , therefore, while it maintains its nuclease activity, this mutant cannot 173 interact with Hfq. The rneΔ14 mutant has a smaller fraction of the C-terminal scaffold (residues 174 636-845) deleted, encompassing the Hfq binding region 50 . In both RNase E mutant backgrounds, 175 the diffusivity of Hfq-mMaple3 became less sensitive to transcription inhibition by rifampicin 176 compared to the WT rne case (Figure 3a and 2c ). 40-50% of Hfq-mMaple3 remained mRNA-177 associated upon rifampicin treatment in the RNase E mutant backgrounds ( Figure 3b ). These 178 observations suggest that without the Hfq-RNase E interaction, more mRNAs remain bound to 179
Hfq, indicating that Hfq may help deliver the associated mRNA to RNase E for degradation. 180 181
Hfq-RNase E interaction contributes to the degradation of Hfq-associated mRNAs 182
To further test the hypothesis that Hfq plays a role in the turnover of certain mRNAs, we used 183 Northern blots to measure the half-lives of selected mRNAs that are known to interact with Hfq in 184 four backgrounds: (Figures 3c and S6 ). In 186 addition to the genetic background of hfq-mMaple3 and rne, we also knocked out the 187 corresponding sRNA regulators of the selected mRNAs (∆ryhB∆fnrS for sodB, ∆cyaR∆micA for 188 ompX and ∆ryhB∆spfΔrybB for sdhC). In the WT rne background, all tested mRNAs (except for 189 icd, to be discussed later) showed an increased half-life in the hfq Y25D-mMaple3 background 190 compared to WT hfq-mMaple3 (Figure 3c ), suggesting that association with Hfq facilitates the 191 turnover of these mRNAs. In the rne131 mutant background, while all mRNAs showed an 192 increased lifetime of 2 to 7-fold compared to the WT rne background, consistent with a 193 compromised activity in the rne131 mutant 49 , the difference in the mRNA half-lives between WT 194 hfq-mMaple3 and hfq Y25D-mMaple3 backgrounds was largely diminished (Figure 3c ). This result 195 indicates that in the absence of Hfq-RNase E interaction, association with Hfq or not does not 196 change the mRNA turnover. As a negative control, icd mRNA, which does not have a putative 197 Hfq binding site, exhibited similar half-lives under WT hfq and hfq Y25D backgrounds (Figure 3c ). 198
These results collectively support that besides the sRNA-mediated pathway, Hfq can regulate 199 certain mRNAs' half-lives by bringing the mRNAs to RNase E for degradation. 200
sRNAs can displace Hfq from mRNAs in a face-dependent manner 202 203
We next examined the effect of sRNAs on the diffusivity of Hfq-mMaple3. We induced expression 204 of different sRNAs , including RyhB, a class I sRNA, ChiX a class II sRNA, and a sRNA that is 205 less clearly defined between these two classes, SgrS 25 . Whereas overexpression of RyhB or SgrS 206 did not cause any noticeable changes in the Hfq-mMaple3 diffusivity or mRNA-associated fraction, 207 overexpression of ChiX dramatically increased its diffusivity and lowered the mRNA-associated 208 fraction (Figure 4a and b). 209
As described above, the distal face is the primary binding site for mRNAs in the cell ( Figure  210 2c). Since ChiX requires binding at both the proximal and distal faces, we expect the diffusivity of 211
Hfq to increase after shifting from mRNA-bound Hfq to ChiX-bound Hfq. Due to the relatively small 212 molecular weight of sRNAs (~50-300 nucleotides in length), sRNA-bound Hfq-mMaple3 has 213 similar diffusivity as free Hfq-mMaple3. We then checked if ChiX could compete with mRNAs for 214 binding to Hfq in vitro using electrophoretic mobility shift assay (EMSA). A radiolabeled fragment 215 of ptsG mRNA was pre-incubated with purified Hfq protein and then chased with unlabeled ChiX. Overexpression of RyhB or SgrS did not cause any significant changes in the Hfq-mMaple3 219 diffusivity or the corresponding mRNA-associated fraction (Figure 4a and b). We reasoned that 220 there might be two possibilities. First, since class I sRNAs bind through the proximal face and the 221 rim of Hfq, it can bind to the mRNA-free Hfq or co-occupy the mRNA-bound Hfq to generate 222 sRNA-bound Hfq or sRNA-mRNA-co-bound Hfq, respectively. Second, class I sRNAs cannot 223 effectively compete against mRNAs for Hfq binding, therefore most Hfq proteins remain 224 associated with mRNAs. To distinguish these two possibilities, we performed an EMSA 225 competition assay using RyhB as an example. Results show that RyhB cannot displace the 226 radiolabeled ptsG from Hfq, but rather generates an additional upper-shifted band compared to 227 the band of ptsG-Hfq complex, supporting that RyhB and ptsG can co-occupy Hfq (Figure 4c , 228 right panel). In addition, droplet digital PCR (ddPCR) performed in the same conditions as the 229 diffusivity assays showed that RyhB level was comparable to ChiX (Figure 4d ). Since RyhB 230 stability is highly dependent on association with Hfq 51 , EMSA and ddPCR results suggest that 231 both in vitro and in vivo, RyhB can effectively access mRNA-occupied Hfq through co-occupying 232
Hfq from the proximal face. 233
To summarize, our results collectively suggest that both class I and class II sRNAs can 234 access mRNA-occupied Hfq in vivo. Class I sRNAs can co-occupy the Hfq protein with an mRNA 235 through different binding sites whereas class II sRNAs can directly compete against the mRNA at 236 the distal face. Interestingly, fluorescence in situ hybridization (FISH) showed a much stronger 237 signal for RyhB compared to ChiX ( Figure S8 ), even though their levels are similar revealed by 238 ddPCR (Figure 4d ). The weaker hybridization signal for ChiX is very likely a reflection of the larger 239 protected region by Hfq on both distal and proximal faces, hindering FISH probe binding. 240 241
Class II sRNAs require interaction with the proximal face and a strong AAN motif to 242 compete for Hfq binding 243
We next sought to understand the molecular features that make ChiX a strong competitor for Hfq 244 binding. When overexpressed in the hfq Q8A-mMaple3 background (proximal face mutation), 245
ChiX lost its capability to displace mRNAs from the mutant Hfq (Figure 5b and c), suggesting that 246 additional binding affinity provided by the proximal face of Hfq is critical for displacing other RNAs 247 from the distal face. E. coli Hfq prefers a (A-A-N) n sequence for distal face binding, where N can 248 be any nucleotide, and each monomer binds to one A-A-N repeat 18 . ChiX contains four AAN motifs 249 ( Figure 5a ). We next determined the effect of AAN motifs on conferring the competitive binding to 250 Hfq over mRNAs. We generated and overexpressed ChiX mutants with one or two AAN motif(s) 251 deleted ( Figure 5a ) and found that the fraction of remaining mRNA-bound Hfq increased when 252 the number of AAN motifs decreased (Figure 5a and c) . Notably, the levels of WT ChiX in the hfq 253 Q8A-mMaple3 background, and the ChiX mutants in the WT hfq-mMaple3 background remained 254 similar as the WT ChiX in WT hfq-mMaple3 background (Figure 4d and 5d ), confirming that the 255 difference we observed in the mutant cases was not due to a change in the cellular ChiX level. 256 257 Discussion 258
Using single-particle tracking, we resolved different diffusivity states of Hfq proteins in live cells, 259 reporting on the interactions with different cellular RNAs. Specifically, free Hfq and sRNA-bound 260
Hfq proteins have the highest diffusivity, and association of mRNAs reduces the diffusivity of Hfq. 261
Utilizing the different diffusivities of mRNA-associated Hfq and mRNA-free Hfq, we directly 262 observed the transition of major interaction partners of Hfq in response to changes in cellular 263 conditions. During exponential growth when sRNAs are least expressed, Hfq proteins are largely 264 occupied by mRNAs through the distal face. Consistent with in vitro binding studies 34-36 , 265 intracellular interactions between Hfq and the mRNA are fairly stable, as indicated by the 266 observation that Hfq cannot release the bound mRNA efficiently in the absence of the interaction 267
with RNase E upon rifampicin treatment. On the other hand, the mRNA binding and RNase E 268 binding capability of Hfq allows it to serve as a "shuttle" by bringing mRNA to RNase E to promote 269 turnover of certain Hfq-associated mRNAs in a sRNA-independent manner (Figure 6a ). 270 Therefore, Hfq-RNase E interaction not only regulates the stability of certain Hfq-associated 271 mRNAs, but also provides one mechanism to recycle Hfq from these mRNAs. 272
Our results suggest that for the selected mRNAs, Hfq can regulate their turnover through a 273 direct recruitment of RNase E. Mechanisms of sRNA-independent Hfq-mediated regulation on 274 mRNA turnover have been reported. First, binding Hfq, or Hfq in complex with other proteins 275 such as Crc, at the ribosome binding site of the mRNA can repress translation 6-8 , therefore 276 indirectly increasing the mRNA degradation due to de-protection of the translating ribosomes 277
against RNase E. Since this translation-dependent regulation of Hfq does not require Hfq-RNase 278 E interaction, if this mechanism applied to the mRNAs we tested, we would expect the difference 279 in half-life between the cases of WT hfq and hfq Y25D to be similar in the WT rne and rne131 280 backgrounds. The observation that the difference in half-life due to Hfq binding is eliminated in 281 the rne131 background suggests the turnover of these mRNAs is not through regulation at the 282 translation level. Second, binding Hfq may recruit polyA polymerase (PAP) and polynucleotide 283 phosphorylase (PNPase) to stimulate polyadenylation at the 3' end, and therefore promote 284 degradation 9,10 , an action that may also require interactions with the C-terminal scaffold region of 285 RNase E. However, this mechanism also cannot fully explain our results for three reasons: (1) 286 Previous studies suggested that Hfq-stimulated polyadenylation prefers Hfq binding at the 3' 287 termini of mRNAs containing Rho-independent transcription terminator 10 . However, in our 288 selected mRNAs, they do not all utilize Rho-independent termination. (2) The Y25D mutant is 289 more likely to hinder mRNA binding through AAN motif on the distal face, rather than through 290 polyU stretch in the Rho-independent terminator, assuming binding of Hfq to the Rho-independent 291 terminator would most likely be through interactions of between the polyU tail and the proximal 292 face.
(3) Our imaging results on Hfq mutants suggest that Hfq binds mRNA mostly through the 293 distal face, indicating that the population of mRNAs with Hfq binding at a Rho-independent 294 terminator would only be a minor fraction, highly consistent with the CLIP-seq results of Hfq 14 . 295 Therefore, it is more likely that the regulation for the selected mRNAs is through direct recruitment 296
of RNase E rather than through Hfq-stimulated polyadenylation mechanism. Nevertheless, Hfq 297 can potentially regulate mRNA turnover through a combination of these three mechanisms in a 298 gene-specific manner. 299
Under the conditions when a specific sRNA is highly induced, we demonstrate how the 300 sRNA can quickly gain access to mRNA pre-occupied Hfq proteins (Figure 6b ). Our results are 301 reminiscent of a previously proposed model of Hfq interacting with sRNAs and mRNAs in a face-302 dependent manner 25 . While the distal face of Hfq is the primary binding site for cellular mRNAs, 303 the rim has a minor binding role, suggesting that the majority of the Hfq-bound mRNAs are class 304 I mRNAs, and a minority are class II mRNAs. This observation is consistent with the previous 305 findings that most of the sRNAs are class I sRNAs 25 . Both classes of sRNAs can easily access 306
Hfq upon induction, albeit with different mechanisms. Surprisingly, class I sRNAs can directly co-307 occupy Hfq through the binding faces that are non-overlapping with the class I mRNA binding 308 face, without the need to displace the pre-occupied mRNA. In contrast, class II sRNAs, such as 309
ChiX, can either co-occupy the minor fraction of Hfq associated with the class II mRNA at the rim, 310 or more likely, can effectively displace class I mRNAs from the distal face. In both cases, the 311 mRNA-occupied Hfq proteins are in standby mode for sRNA binding if needed. The displacement 312 of mRNA by the class II sRNA requires both the interactions at the proximal face of Hfq and higher 313 AAN motif number to outcompete mRNAs for the binding at the distal face. In addition, we propose 314 that the competitive binding by the class II sRNA is likely to occur stepwise, with binding at the 315 proximal face happening first, followed by the displacement of mRNA form the distal face, which 316 is supported by the observation that with the Hfq proximal face mutation, ChiX cannot displace 317 mRNAs, even with a strong AAN motif. Importantly, our mutational work demonstrates that it 318 should be possible to engineer Hfq-RNA interactions in vivo. Given the complete absence of 319 sRNA-mediated gene regulation in eukaryotes, our results provide a framework for developing 320 biotechnological tools that will potentially enable precise control over the sequestration, 321 degradation, and/or expression of target mRNAs in eukaryotes. 322
323
Methods 324
Bacterial Strains 325
Transfer of the Linker-mMaple3-Kan sequence at the 3' end of chromosomal hfq gene was 326 achieved by following the PCR-based method 52 with a few modifications. First, a PCR (PCR1) 327 was performed using plasmid pZEA93M as template to amplify the mMaple3 sequence (oligos 328 EM4314-4293). Then, to add sequence homology of hfq gene, a second PCR (PCR2) was 329 performed using PCR1 as template (oligos EM4313-4293). The final PCR product (PCR3), 330 containing a flippase recognition target (FRT)-flanked kanamycin resistance cassette was 331 generated from pKD4 plasmid with primers PCR2 and EM1690 carrying extensions homologous 332 to the hfq gene. PCR3 was then purified and transformed to WT (EM1055), hfq Y25D (KK2562), 333 hfq Q8A (KK2560), hfq K31A (AZZ41) or hfq R16A (KK2561) strains containing the pKD46 334 plasmid using electroporation, to obtain strains with hfq-Linker-mMaple3-Kan, hfq Y25D-Linker-335 mMaple3-Kan, hfq Q8A-Linker-mMaple3-Kan, hfq K31A-Linker-mMaple3-Kan, and hfq R16A-336
Linker-mMaple3-Kan, respectively. Hfq mutations F42A and R19D were obtained by performing 337
PCRs on fusion strains KP1867 (Hfq-linker-mMaple3) with oligos EM4704-1690 (Hfq F42A) or 338 EM4705-1690 (Hfq R19D). Fragments were then transformed to WT (EM1055) containing the 339 pKD46 plasmid, following induction of the λ Red. P1 transduction was used to transfer the linked 340 fluorescent protein and the antibiotic resistance gene into a WT (EM1055), rne131 (EM1377) or 341 rne∆14 (EM1376) strains. 342 fnrS, micA and spf knock-outs were obtained through transformation of PCR products into 343 EM1237 after induction of λ red and selecting for kanamycin or chloramphenicol resistance. P1 344 transduction was used to transfer the knock-out mutations and the antibiotic resistance gene into 345 appropriate strains. Selection was achieved with kanamycin or chloramphenicol. When 346 necessary, FRT-flanked antibiotic resistance cassettes were eliminated after transformation with 347 pCP20, as described 52 . All constructs were verified by sequencing and are listed in Table S1 . 348
Oligonucleotides used for generating constructs are listed in Table S2 . 349
350
Plasmids 351 E. coli MG1655 sRNA genes sgrS, ryhB, and chiX were inserted into the pET15b low copy number 352 vector plasmid (kind gift from Perozo lab) to create plasmids pET16b-RyhB, pET15b-SgrS and 353 pET15b-ChiX using Gibson Assembly (in house) using oligos listed in Table S2 . The chiX ΔAAN 354 mutants were made using site directed mutagenesis. Primers EH159, EH160 and EH161 355 homologous to chiX while excluding the AAN domain were used to amplify the plasmid. The 356 products were phosphorylated (NEB M0201S) and ligated (NEB M0202S) before transformation. 357
Cloning of pBAD-micA was performed by PCR amplification of micA (oligos EM2651-2652) 358 on WT strain (EM1055). The PCR product was digested with SphI and cloned into a pNM12 vector 359 digested with MscI and SphI. All constructs were verified by sequencing and are listed in Table  360 S1. Oligos used for generating the constructs are listed in Table S2 . 361 362
Growth conditions for imaging experiments 363
Overnight cultures of E. coli strains were diluted by 1:100 in MOPS EZ rich defined medium 364 (Teknova). 0.2% glucose was used as the carbon source for imaging Hfq-mMaple3 WT and 365 mutants under NT and rifampicin treated conditions. 0.2% glycerol was used as the carbon source 366 with 100 µg/mL ampicillin for mMaple3 control (SP191). 0.2% fructose was used as the carbon 367 source with 100 µg/mL ampicillin for cases with sRNA overexpression. Cultures were grown at 368 37 °C aerobically. Plasmid-encoded sRNAs and plasmid-encoded mMaple3 proteins were 369 induced by IPTG (1 mM and 100~400 μM respectively) when the OD 600 of the cell culture was 370 ~0.1. Induced cells were grown for ~45 minutes before imaging. For the rifampicin treatment, 371 rifampicin was added to a final concentration of 200 μg/mL when the OD 600 of the cell culture was 372 ~0.2, and the cells were incubated for 15 minutes before imaging. 373 374
Growth curve measurement 375
The bacterial strains were grown overnight in LB or MOPS EZ-rich medium containing 0.2% 376 glucose. Cultures were diluted to 6 x 10 6 cells/mL in their respective medium and samples were 377 prepared in triplicate by mixing 50 µL of cells and 50 µL of fresh media to obtain 3 x 10 6 cells/mL. 378
Assay were performed in Microtest plate, 96-well, flat base, polystyrene, sterile (Sarstedt) and 379 growth was monitored using Epoch 2 Microplate Spectrophotometer reader (BioTek) with the 380 following settings: OD= 600 nm, Temperature= 37 °C, Reading= every 10 min for 22 h, 381
Continuous shaking. 382
383

RNA extraction and Northern blot analysis 384
Total RNA was extracted following the hot-phenol protocol as described 53 . To test the function of 385 the mMaple3-tagged Hfq and compare that with the WT Hfq, cells were grown in LB to the OD 600 386 of 0.5 and either RyhB was induced by adding of 2.2′-dipyridyl in a WT hfq or in an hfq-mMaple3 387 background, or MicA was induced by addition of 0.1% arabinose (ara) in a ΔmicA WT hfq or in a 388
ΔmicA hfq-mMaple3 background (pBAD-micA). 389
Determination of RNA half-life was performed in MOPS EZ rich defined medium (Teknova) 390 with 0.2% glucose by addition of 500 μg/mL rifampicin to the culture at the OD 600 of 0.5 before 391 total RNA extraction. Northern blots were performed as described previously 54 with some 392 modifications. Following total RNA extraction, 5~10 μg of total RNA was loaded on polyacrylamide 393 gel (5% acrylamide 29:1, 8 M urea) and 20 μg was loaded on agarose gel (1%, 1X MOPS). 394
Radiolabeled DNA and RNA probes used in this study are described in Table S2 . The radiolabeled 395 RNA probes used for Northern blot analysis were transcribed with T7 RNA polymerase from a 396 PCR product to generate the antisense transcript of the gene of interest 55 . Membranes were then 397 exposed to phosphor storage screens and analyzed using a Typhoon Trio (GE Healthcare) 398 instrument. Quantification was performed using the Image studio lite software (LI-COR). 399
The decay rate of mRNA degradation was calculated as previously described 56 . Briefly, the 400 intensity of Northern blot at each time point upon adding rifampicin was normalized to the intensity 401 at time zero, and was fit by a piecewise function in the log space: 402 ln ln 0 , ln 0 , 403 Where I t is the normalized intensity at time t, I 0 is the normalized intensity at time zero, k is 404 the rate of exponential decay and α is the duration of the initial delay before the exponential decay Table  419 S2. Each reaction mix (20 µL) was converted to droplets with the QX200 droplet generator (Bio-420 Rad). Droplet-partitioned samples were then transferred to a 96-well plate, sealed and cycled in 421 a C1000 deep well Thermocycler (Bio-Rad) under the following cycling protocol: 95 °C for 5 min 422 (DNA polymerase activation), followed by 50 cycles of 95 °C for 30 s (denaturation), 59 °C for 1 423 min (annealing) and 72 °C for 30 s (extension) followed by post-cycling steps of 4 °C for 5 min 424 and 90 °C for 5 min (Signal stabilization) and an infinite 12 °C hold. The cycled plate was then 425 transferred and read using the QX200 reader (Bio-Rad) either the same or the following day post-426 cycling. The concentration reported is copies/μL of the final 1x ddPCR reaction (using QuantaSoft 427 software from Bio-Rad) 57 . 428 429
Hfq purification 430
Hfq was purified following the previously described procedure 58 with modifications. Briefly, strain 431 EM1392 containing pET21b-hfq was grown at 37 °C in LB medium supplemented with 50 μg/mL 432 ampicillin and 30 μg/mL chloramphenicol until it reached an OD 600 =0.6. Hfq expression was 433 induced by addition of 5 mM IPTG (Bioshop) for 3 h. Cells were pelleted by centrifugation (15 min, 434 3825g) and resuspended in 4 mL Buffer C (50 mM Tris-HCl pH 7.5, 1 mM EDTA, 50 mM NH 4 Cl, 435 5% glycerol) 59 supplemented with 30 U Turbo DNase (Ambion). Cells were lysed by sonication 436 for 4 min (amplitude 25%, cycles of 5 sec sonication, 5 sec on ice) and samples were cleared by 437 centrifugation (45 min, 12,000g). The supernatant was incubated at 80 °C for 10 min, centrifuged 438 again (20 min, 12,000g) and cleared by filtration. radiolabeled ptsG was first incubated for 15 min at 37 °C with 100 nM Hfq (as described above). 467 Specific concentrations of RyhB or ChiX (0-100 nM) were added to the samples and incubation 468 was carried out for 15 min at 37 °C. Reactions were stopped by addition of 1 μL non-denaturing 469 loading buffer. Sample were loaded on native polyacrylamide gels (5% acrylamide:bisacrylamide 470 29:1) in cold TBE 1X and migrated at 50 V, at 4 °C. Gels were dried and exposed to phosphor 471 storage screens and analyzed using a Typhoon Trio (GE Healthcare) instrument. When 472 applicable, quantification was performed using the Image studio lite software (LI-COR) and data 473 was fitted using non-linear regression (GraphPad Prism). 474 475
Fluorescence in situ hybridization (FISH) 476
Sample preparation for fixed cells was performed mostly according to the protocol previously 477 reported 61,62 . Briefly, ~10 mL of cells was collected and fixed with 4% formaldehyde in 1x PBS for 478 30 minutes at room temperature (RT). The fixed cells were then permeabilized with 70% ethanol 479 for 1 hour at RT. Permeabilized cells can be stored in 70% ethanol at 4 °C until the sample 480 preparation. FISH probes were designed and dye-labeled as in the previous report 61,62 . 481 Hybridization was performed in 20 μL of hybridization buffer (10% dextran sulfate (Sigma D8906) 482 and 10% formamide in 2x SSC) containing specific sets of FISH probes at 30 °C in the dark 483 overnight. The concentration of FISH probes was 50 nM. After hybridization, cells were washed 484 three times with 10% FISH wash buffer (10% formamide in 2x SSC) at 30 °C.. 485 486
Live-cell single-particle tracking and fixed cell SMLM imaging 487
Imaging was performed on a custom built microscopy setup previously described 63 For live-cell single particle tracking, 1 mL of cell culture was centrifuged by 1,500g for 5 min 498 and 970 µL of the supernatant was removed. The remaining volume was mixed well and ~1.5 µL 499 was covered by a thin piece of 1% agarose gel on an ethanol-cleaned-and-flamed coverslip 500 sealed to a custom 3D printed chamber. The agarose gel contained the same concentration of 501 any drug or inducer used in each condition. Exceptions include rifampicin, which was at 100 502 μg/mL in the gel, due to high imaging background caused by high concentration of rifampicin, and 503 IPTG for SP191 culture, which was eliminated in the gel, due to the high abundance mMaple3 504 already induced by IPTG in the culture. The power density of the 561 nm laser for single-particle 505 tracking was ~2750 W/cm 2 , and the power density of the 405 nm laser was ~7 W/cm 2 (except for 506 SP191 where ~4.5 W/cm 2 was used due to high abundance of mMaple3). 1.5x Tube lens was 507 used for the microscope body, and 2x2 binning mode was used for the camera. In this way, the 508 effective pixel size became larger (173 nm instead of original 130 nm), receiving 77% more 509 photons per pixel. 10 frames with 561 nm excitation were taken after each frame of 405 nm photo-510 conversion. About 13000 frames were collected per movie at a rate of 180 frames per second. 511
For fixed-cell control experiment for tracking parameter optimization, imaging was performed 512 using the exactly same imaging parameters as in live-cell measurements for a fair comparison. 513
In cases imaging DNA together, Hoechst dye (Thermo 62249) was added to the ~30 µL of cell 514 culture before imaging as ~20 µM final concentration, and imaged by the LED lamp (12%) with 515 500 ms exposure time. Imaging acquisition was conducted by NIS-Element (Nikon) software, at 516
RT. 517
518
Image reconstruction 519
The SMLM images are reconstructed as previously descried 62 , by a custom code written in IDL 520 (Interactive Data Language). Briefly, all the pixels with an intensity value above the threshold were 521 identified in each frame. The threshold was set at 3 times of the standard deviation of the 522 individual frame pixel intensity. Among those pixels, the ones having larger values than 523 surrounding pixels in each 5x5 pixel region are identified again as possible peak candidates, and 524 2D Gaussian function was fitted to a 15x15 pixel region surrounding these candidates. Candidates 525 with failed fitting were discarded, and precise peak positions are defined for the remaining ones. 526
The horizontal drift, which often occurs during the imaging acquisition, was corrected by fast 527 Fourier transformation analysis. 528 529
Tracking analysis 530
We used a MATLAB coded tracking algorithm to generate diffusion trajectories, which was 531 modified by Sadoon and Yong 64 based on the previously developed code 65 . Per each time step 532 of ~5.6 ms, 250 nm was empirically chosen to be the maximum one-step displacement to reduce 533 artificial diffusion trajectories connected between different molecules, using a fixed cell sample as 534 a control ( Figure S3B 
